Search Results

Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil

Authors: Krishnamoorthy, Suresh; Lip, Gregory YH

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 8, August 2009 , pp. 1191-1196(6)

Publisher: Informa Healthcare

The transmembrane β-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current I _to

Authors: Radicke, Susanne; Cotella, Diego; Sblattero, Daniele; Ravens, Ursula; Santoro, Claudio; Wettwer, Erich

Source: Naunyn-Schmiedeberg's Archives of Pharmacology, Volume 379, Number 6, June 2009 , pp. 617-626(10)

Publisher: Springer

Ionic Basis of Pharmacological Therapy in Brugada Syndrome

Authors: MÁRQUEZ, MANLIO F.; SALICA, GABRIEL; HERMOSILLO, ANTONIO G.; PASTELÍN, GUSTAVO; GÓMEZ-FLORES, JORGE; NAVA, SANTIAGO; CÁRDENAS, MANUEL

Source: Journal of Cardiovascular Electrophysiology, Volume 18, Number 2, February 2007 , pp. 234-240(7)

Publisher: Blackwell Publishing

Do we need pharmacological therapy for atrial fibrillation in the ablation era?

Author: Lévy, Samuel

Source: Journal of Interventional Cardiac Electrophysiology, Volume 17, Number 3, December 2006 , pp. 189-194(6)

Publisher: Springer

Future directions in antiarrhythmic drug therapy for atrial fibrillation

Authors: Musco, Simone; Seltzer, Jonathan; Kowey, Peter R

Source: Future Cardiology, Volume 2, Number 5, September 2006 , pp. 545-553(9)

Publisher: Future Medicine

Drug Therapy in Brugada Syndrome

Authors: Marquez, Manlio F.; Salica, Gabriel; Hermosillo, Antonio G.; Pastelin, Gustavo; Cardenas, Manuel

Source: Current Drug Targets - Cardiovascular & Hematological Disorders, Volume 5, Number 5, October 2005 , pp. 409-417(9)

Publisher: Bentham Science Publishers

Tedisamil sesquifumarate

Authors: Jones, Peter G.; Schön, Uwe; Finner, Emil

Source: Acta Crystallographica Section E, Volume 60, Number 8, August 2004 , pp. o1285-o1287(1)

Publisher: Blackwell Publishing

Effect of the Antifibrillatory Compound Tedisamil (KC-8857) on Transmembrane Currents in Mammalian Ventricular Myocytes

Authors: N. Jost; L. Virag; O. Hala; A. Varro; D. Thormahlen; J. G.y. Papp

Source: Current Medicinal Chemistry, Volume 11, Number 24, December 2004 , pp. 3219-3228(10)

Publisher: Bentham Science Publishers

Tedisamil converts atrial flutter, fibrillation to normal sinus rhythm

Source: Inpharma, Volume 1, Number 1447, 2004-07-24 , pp. 6-6(1)

Publisher: Adis International

Tedisamil: a new novel antiarrhythmic

Authors: Freestone B.; Lip G.Y.

Source: Expert Opinion on Investigational Drugs, Volume 13, Number 2, 1 February 2004 , pp. 151-160(10)

Publisher: Informa Healthcare

Theoretical Possibilities for the Development of Novel Antiarrhythmic Drugs

Authors: Varro Andras; Biliczki Peter; Iost Norbert; Virag Laszlo; Hala Otto; Kovacs Peter; Matyus Peter; Papp Julius G.y.

Source: Current Medicinal Chemistry, Volume 11, Number 1, January 2004 , pp. 1-11(11)

Publisher: Bentham Science Publishers

Trials of New Antiarrhythmic Drugs for Maintenance of Sinus Rhythm in Patients with Atrial Fibrillation: Current Topics in the Management of Atrial Fibrillation

Author: Singh S.

Source: Journal of Interventional Cardiac Electrophysiology, Volume 10, Supplement 1, February 2004 , pp. 71-76(6)

Publisher: Springer

Modulation of intracellular Ca²⁺ concentration by tedisamil, a class III antiarrhythmic agent, in isolated heart preparation

Authors: Seki S.; Tribulova N.; Manoach M.; Mochizuki S.

Source: Life Sciences, Volume 73, Number 14, 22 August 2003 , pp. 1805-1811(7)

Publisher: Elsevier

Tedisamil blocks BK-type Ca²⁺-dependent K⁺ channels and modulates action potentials in rat hippocampal neurons

Authors: Church J.; McLarnon J.G.

Source: Neuroscience Letters, Volume 319, Number 2, 15 February 2002 , pp. 79-82(4)

Publisher: Elsevier

Conversion of Atrial Fibrillation by the Experimental Antiarrhythmic Drug Tedisamil in Two Canine Models

Authors: FISCHBACH P.S.; BARRETT T.D.; GOYAL R.; TRAN B.C.; SYED Z.A.; HENNAN J.K.; LUCCHESI B.R.

Source: Journal of Cardiovascular Electrophysiology, Volume 12, Number 10, October 2001 , pp. 1138-1144(7)

Publisher: Blackwell Publishing

Tedisamil: master switch of nature?

Author: Doggrell S.A.

Source: Expert Opinion on Investigational Drugs, Volume 10, Number 1, January 2001 , pp. 129-138(10)

Publisher: Informa Healthcare

Transgenic mice overexpressing human KvLQT1 dominant-negative isoform Part II: Pharmacological profile

Authors: Lande G.; Demolombe S.; Bammert A.; Moorman A.; Charpentier F.; Escande D.

Source: Cardiovascular Research, Volume 50, Number 2, May 2001 , pp. 328-334(7)

Publisher: Elsevier

Modulation of cAMP level by tedisamil in guinea pig heart

Authors: Tribulova N.; Ravingerova T.; Okruhlicova L.; Gabauer I.; Fickova M.; Pancza D.; Slezak J.; Manoach M.

Source: Molecular and Cellular Biochemistry, Volume 210, Numbers 1-2, July 2000 , pp. 75-80(6)

Publisher: Springer

Salutary effect of tedisamil on post-ischemic recovery rat heart: Involvement of sarcolemmal (Na,K)-ATPase

Authors: Durba A.; Ziegelhöffer A.; Okruhlicová L.; Styk J.

Source: Molecular and Cellular Biochemistry, Volume 215, Numbers 1-2, December 2000 , pp. 129-133(5)

Publisher: Springer

Hemodynamic, Antiischemic, and Neurohumoral Effects of Tedisamil and Atenolol in Patients with Coronary Artery Disease

Authors: Mitrovic V.; Miskovic A.; Straub M.; Thormann J.; Pitschner H.; Hamm C.

Source: Cardiovascular Drugs and Therapy, Volume 14, Number 5, October 2000 , pp. 511-521(11)

Publisher: Springer